Staburo will take part in this year’s BVMA symposium on 24 November 2017, at the Westin Grand Hotel München, here in Munich. The BVMA represents the interests of its German CRO members. The BVMA members maintain a lively exchange of information on all topics that are...

Staburo's Head of Biostatistics Dr. Hannes Buchner took part in the first Roche Future X Healthcare 2017 event in Munich. The topic was „Making Data Meaningful – from Science to Patients“, a motto that could easily fit to our daily work at Staburo. The agenda started...

Staburo's Managing Director Roland Stieger joined the BIO-Europe for the third time and enjoyed the good organization and networking opportunities of this partnering conference. The event started with a great panel discussion, with relevance for Staburo "The evolving...

In this talk, an introduction into CDISC, especially in SDTM and the strategy how to program it, were presented. The talk started with general information and important terms about the fundamentals of SDTM. We discussed the different kinds of datasets and how...

The first presentation of this year’s traditional “Wiesn” workshop was about the statistical method “Analysis of Variance”. It is a very useful tool to examine the influence of one or more categorical variables on a continuous target variable and applies to many types...

We are very proud to welcome Michael Matiu in our team. Michael will support our clients with his experience in biostatistics and his profound statistical programming background. We are looking forward to a great and long-lasting cooperation!  

Statistics Workshop It is a very nice tradition to have a Staburo statistics training session on the first Monday of the two-week Oktoberfest period. This year, the Staburo team had the chance to learn more about the ANOVA method plus SAS/R programming advice. In the...

Staburo's biostatisticians and statistical programmers enjoyed a wonderful event that was combining team spirit, mental strength, physical fitness and a lot of fun. We spent a great afternoon - not in a Random Forest - but in the Climbing Forest near Munich...

Staburo submitted comments on EMA's draft guideline on multiplicity issues in clinical trials. Multiplicity issues arise in many areas of clinical development, including biosimilars  and translational medicine. The guideline is intended to provide guidance on how to...